Eisai Trial Site 1

Chuo-ku, Tokyo

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma

Studies at this site

• A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma — Completed